Key Risk Factors Affecting Treatment Choice in Melanoma with Dr. G. Gary Tian

Posted by & filed under Uncategorized.

Key Risk Factors Affecting Treatment Choice in Melanoma   West provider, Dr. G. Gary Tian, joins Dr. Evan J. Lipson with John Hopkins Medicine and other oncology experts to discuss critical factors influencing physicians’ decisions between monotherapy and doublet therapy for Metastatic Melanoma.   The group dives into the latest treatment options for metastatic melanoma,… Read more »

Standard-of-Care Treatment Approaches for HR+/HER2 Early Breast Cancer ft. Dr. Gregory Vidal

Posted by & filed under Uncategorized.

In a recent OncLive Peer Exchange, Dr. Gregory Vidal partnered with a panel of breast oncology experts to discuss the standard-of-care treatment approaches for early-stage HR-positive/HER2-negative breast cancer.   Topics include: – Evolution of HER2-negative management – Updates in HR-positive treatment – Importance of genetic testing – Utilization of endocrine therapy – BRCA mutations and… Read more »

Gynecologic Cancer

Posted by & filed under Uncategorized.

There are over 110,000 new gynecologic cancers diagnosed each year in the US and 79% of patients in the Mid-South trust in West Cancer Center & Research Institute for their care. We treat all gynecologic cancers including Uterine, which is the most common, Cervical, Ovarian, Vulvar and Vaginal. Our team of specialists include gynecologic oncologists,... Read more »

Meet Judy: Esophageal Cancer Survivor

Posted by & filed under Uncategorized.

Meet Judy: Esophageal Cancer Survivor   Judy came to our West family after she and her husband moved from Florida to Memphis post-retirement. While in Florida, Judy was at high risk for developing esophageal cancer and received frequent screenings to ensure early detection. She was ultimately diagnosed with Stage IV esophageal cancer and would have… Read more »

Lung Cancer

Posted by & filed under Uncategorized.

Our lung cancer team is recognized by the community as exceptional from prevention and diagnosis to the latest treatments. Lung cancer is one of the most common types of cancer, but the good news is the growing number of new therapies. At West Cancer Center & Research Institute, our specialists can provide you with new... Read more »

Updates in GI Cancers with Dr. Axel Grothey

Posted by & filed under Uncategorized.

Exciting updates in GI Cancers! Dr. Axel Grothey from West Cancer Center shared groundbreaking insights at the Total Health Spring Oncology Review and Renew Conference. He highlighted major advancements in targeted therapies and precision medicine for GI cancers. Here are the key highlights: Gastro-Esophageal Junction (GEJ) Cancers: Dr. Grothey revealed a new biomarker, Claudin 18.2… Read more »

Genitourinary (Urinary) Cancers

Posted by & filed under Uncategorized.

Genitourinary cancers account for 11% of all cancers and 23% of all cancer deaths in the US each year. Trusting your care to a team of specialists is key to thriving and surviving. At West Cancer Center & Research Institute our comprehensive, personalized approach to cancer care is unique in the Mid-South. In 2022, West... Read more »

Cancer Updates: Free Dinner Series for Regional Providers

Posted by & filed under Uncategorized.

CALLING ALL REGIONAL PROVIDERS From now through November, our West family is partnering with Total Health Conferencing to host “Cancer Updates: A Dinner Series for Community Care Teams.” These dinners will consist of educational discussions designed for oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of various cancers. Each tumor-focused program is comprised… Read more »

Download Our Mobile App

Posted by & filed under Uncategorized.

Apple App Store Google Play Store Our West Cancer Center mobile app is available for both Apple and Android devices. Just search "West Cancer Center" in your app store to download. Users can access their CareSpace patient portal, view and pay their bill online, and receive clinic-wide updates with ease. For assistance, please contact [email protected].

100% Response Rate in Skin Cancer Trial

Posted by & filed under Uncategorized.

Our West family is 1 of only 2 sites across the country to host this clinical trial for patients with recurrent or unresectable skin cancers. “After 12 weeks post-treatment, complete response was observed in all 10 patients (100%)! CT scans at 24 weeks post-treatment showed NO EVIDENCE OF RECURRENT DISEASE in any of the patients.”… Read more »